Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages 3864-3872

  Bidet, Maud ^a,b   Bachelot, Anne ^a,b   Bissauge, Estelle ^a,b   Golmard, Jean Louis ^a   Gricourt, Solenne ^a,b   Dulon, Jeŕom̂e ^a,b   Coussieu, Christiane ^a   Badachi, Yasmina ^a   Touraine, Philippe ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; INHIBIN B;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BIOPSY; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVARY FUNCTION; PREDICTIVE VALUE; PREGNANCY; PREMATURE OVARIAN FAILURE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SECONDARY AMENORRHEA; ULTRASOUND; UNIVARIATE ANALYSIS;

ADULT; ANTI-MULLERIAN HORMONE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INHIBINS; LUTEINIZING HORMONE; OVARY; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PRIMARY OVARIAN INSUFFICIENCY; RECOVERY OF FUNCTION; TESTOSTERONE;

EID: 83155168475     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1038     Document Type: Article

References (38)

1. Beck-Peccoz P, Persani L 2006 Premature ovarian failure. Orphanet J Rare Dis 1:9
2. Nelson LM 2009 Clinical practice. Primary ovarian insufficiency. N Engl J Med 360:606-614
3. Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM 1997 Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 89:777-779 (Pubitemid 27184865)
4. Rebar RW, Erickson GF, Yen SS 1982 Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 37:35-41 (Pubitemid 12207214)
5. Rebar RW, Connolly HV 1990 Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 53:804-810 (Pubitemid 20180467)
6. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, Shawker TH, Merino MJ 1994 Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 79:1470-1475 (Pubitemid 24369868)
7. Conway GS 1996 Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol (Oxf) 45:657-663 (Pubitemid 27032310)
8. Taylor AE, Adams JM, Mulder JE, Martin KA, Sluss PM, Crowley Jr WF 1996 A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab 81:3615-3621 (Pubitemid 26339926)
9. Bachelot A, Rouxel A, Massin N, Dulon J, Courtillot C, Matuchansky C, Badachi Y, Fortin A, Paniel B, Lecuru F, Lefrère-Belda MA, Constancis E, Thibault E, Meduri G, Guiochon-Mantel A, Misrahi M, Kuttenn F, Touraine P 2009 Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure. Eur J Endocrinol 161:179-187
10. Kreiner D, Droesch K, Navot D, Scott R, Rosenwaks Z 1988 Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure. Obstet Gynecol 72:926-928
11. Bidet M, Bachelot A, Touraine P 2008 Premature ovarian failure: predictability of intermittent ovarian function and response to ovulation induction agents. Curr Opin Obstet Gynecol 20:416-420
12. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS 1996 Characterization of idiopathic premature ovarian failure. Fertil Steril 65:337-341 (Pubitemid 26043830)
13. Nelson LM, Kimzey LM, White BJ, Merriam GR 1992 Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril 57:50-55
14. Wallace WH, Kelsey TW 2004 Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Hum Reprod 19:1612-1617
15. van Kasteren YM, Hoek A, Schoemaker J 1995 Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertil Steril 64:273-278
16. van Kasteren YM, Schoemaker J 1999 Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 5:483-492 (Pubitemid 29512134)
17. Surrey ES, Cedars MI 1989 The effect of gonadotropin suppression on the induction of ovulation in premature ovarian failure patients. Fertil Steril 52:36-41 (Pubitemid 19178690)
18. Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G 2007 Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril 87:858-861 (Pubitemid 46566354)
19. Badawy A, Goda H, Ragab A 2007 Induction of ovulation in idiopathic premature ovarian failure: a randomized double-blind trial. Reprod Biomed Online 15:215-219 (Pubitemid 47263331)
20. Conway GS 2010 Premature ovarian failure and FMR1 gene mutations: an update. Ann Endocrinol (Paris) 71:215-217
21. Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A, Bellastella A, Santeusanio F, De Bellis A 2002 Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril 78:270-279 (Pubitemid 34831727)
22. O'Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, Kaye J, Walsh JP 2006 Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol (Oxf) 64:97-104
23. Welt CK, Hall JE, Adams JM, Taylor AE 2005 Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure. J Clin Endocrinol Metab 90:826-830 (Pubitemid 40279204)
24. Broekmans FJ, Soules MR, Fauser BC 2009 Ovarian aging: mechanisms and clinical consequences. Endocr Rev 30:465-493
25. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, Harlow S, Randolph Jr JF 2008 Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 93:3478-3483
26. Durlinger AL, Visser JA, Themmen AP 2002 Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 124:601-609 (Pubitemid 35402334)
27. Fanchin R, Salomon L, Castelo-Branco A, Olivennes F, Frydman N, Frydman R 2003 Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 18:2698-2703 (Pubitemid 37536643)
28. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P 2004 Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 82:1323-1329 (Pubitemid 39469455)
29. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM 2002 Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77:468-471 (Pubitemid 34177199)
30. van Disseldorp J, Faddy MJ, Themmen AP, de Jong FH, Peeters PH, van der Schouw YT, Broekmans FJ 2008 Relationship of serum antimullerian hormone concentration to age at menopause. J Clin Endocrinol Metab 93:2129-2134 (Pubitemid 351831526)
31. Massin N, Méduri G, Bachelot A, Misrahi M, Kuttenn F, Touraine P 2008 Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure. Mol Cell Endocrinol 282:95-100
32. Méduri G, Massin N, Guibourdenche J, Bachelot A, Fiori O, Kuttenn F, Misrahi M, Touraine P 2007 Serum anti-Mullerian hormone expression in women with premature ovarian failure. Hum Reprod 22:117-123 (Pubitemid 44942674)
33. Tremellen K, Kolo M 2010 Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy. Aust N Z J Obstet Gynaecol 50:568-572
34. Gleicher N, Weghofer A, Barad DH 2010 Discordances between follicle stimulating hormone (FSH) and anti-Mullerian hormone (AMH) in female infertility. Reprod Biol Endocrinol 8:64
35. Benetti-Pinto CL, Bedone AJ, Magna LA 2005 Evaluation of serum androgen levels in women with premature ovarian failure. Fertil Steril 83:508-510 (Pubitemid 40221821)
36. Bachelot A, Meduri G, Massin N, Misrahi M, Kuttenn F, Touraine P 2005 Ovarian steroidogenesis and serum androgen levels in patients with premature ovarian failure. J Clin Endocrinol Metab 90:2391-2396 (Pubitemid 40586289)
37. Mamas L, Mamas E 2009 Premature ovarian failure and dehydroepiandrosterone. Fertil Steril 91:644-646
38. Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A 2010 Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 25:2496-2500